Crossmark

First synthesis of novel 2,4-bis((<i>E</i>)-styryl)quinoline-3-carboxylate derivatives and their antitumor activity

Crossref DOI link: https://doi.org/10.1039/C8RA08023B

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Gao, Wentao

Li, Zhiyuan

Xu, Qiqi

Li, Yang https://orcid.org/0000-0003-0427-6509
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21402011, 21476028)

Natural Science Foundation of Liaoning Province (201602006)
License Information

Version of Record valid from 2018-11-19
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yang Li (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 27 September 2018; Accepted 12 November 2018; Version of Record published 19 November 2018